177 related articles for article (PubMed ID: 6216863)
21. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.
Wanebo HJ; Pace R; Hargett S; Katz D; Sando J
Cancer; 1986 Feb; 57(3):656-62. PubMed ID: 3484660
[TBL] [Abstract][Full Text] [Related]
22. Immune dysfunction in primary biliary cirrhosis. II. Increased production of prostaglandin E.
Chiricolo M; Lenzi M; Bianchi F; Franceschi C; Bartolini G; Orlandi M; Tomasi V; Licastro F
Scand J Immunol; 1989 Sep; 30(3):363-7. PubMed ID: 2789430
[TBL] [Abstract][Full Text] [Related]
23. Augmentation of prostaglandin and thromboxane production in vitro by monocytes exposed to histamine-induced suppressor factor (HSF).
Rocklin RE; Kiselis I; Beer DJ; Rossi P; Maggi F; Bellanti JA
Cell Immunol; 1983 Apr; 77(1):92-8. PubMed ID: 6573232
[TBL] [Abstract][Full Text] [Related]
24. Decreased sensitivity of atopic mononuclear cells to prostaglandin E2 (PGE2) and prostaglandin D2 (PGD2).
Rocklin RE; Thistle L; Audera C
J Immunol; 1985 Sep; 135(3):2033-9. PubMed ID: 3160784
[TBL] [Abstract][Full Text] [Related]
25. Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.
Fischer A; Durandy A; Griscelli C
J Immunol; 1981 Apr; 126(4):1452-5. PubMed ID: 6451647
[TBL] [Abstract][Full Text] [Related]
26. Regulation of NK cell activity by prostaglandin E2: the role of T cells.
Zielinski CC; Gisinger C; Binder C; Mannhalter JW; Eibl MM
Cell Immunol; 1984 Aug; 87(1):65-72. PubMed ID: 6611214
[TBL] [Abstract][Full Text] [Related]
27. Neck node immunoreactivity in head and neck carcinoma.
Mandell-Brown M; Johnson JT; Rabin BS; Hamill E; Wagner RL
Otolaryngol Head Neck Surg; 1986 Nov; 95(4):500-6. PubMed ID: 2952933
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of prostaglandin E2 production by mononuclear cells and tumor cells in squamous cell carcinomas of the head and neck.
Milanovich MR; Snyderman CH; Wagner R; Johnson JT
Laryngoscope; 1995 Jan; 105(1):61-5. PubMed ID: 7837915
[TBL] [Abstract][Full Text] [Related]
29. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
Passwell J; Levanon M; Davidsohn J; Ramot B
Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of altered monocyte prostaglandin E2 production in severely injured patients.
Miller-Graziano CL; Fink M; Wu JY; Szabo G; Kodys K
Arch Surg; 1988 Mar; 123(3):293-9. PubMed ID: 2963603
[TBL] [Abstract][Full Text] [Related]
31. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
32. Comparison of in vivo and in vitro prostaglandin E2 production by squamous cell carcinoma of the head and neck.
Snyderman CH; Klapan I; Milanovich M; Heo DS; Wagner R; Schwartz D; Johnson JT; Whiteside TL
Otolaryngol Head Neck Surg; 1994 Sep; 111(3 Pt 1):189-96. PubMed ID: 8084624
[TBL] [Abstract][Full Text] [Related]
33. Strong prostaglandin associated suppression of the proliferation of human maternal lymphocytes by neonatal lymphocytes linked to T versus T cell interactions and differential PGE2 sensitivity.
Papadogiannakis N; Johnsen SA; Olding LB
Clin Exp Immunol; 1985 Jul; 61(1):125-34. PubMed ID: 2931220
[TBL] [Abstract][Full Text] [Related]
34. Collagens act as ligands to stimulate human monocytes to produce mononuclear cell factor (MCF) and prostaglandins (PGE2).
Dayer JM; Trentham DE; Krane SM
Coll Relat Res; 1982 Nov; 2(6):523-40. PubMed ID: 6301748
[TBL] [Abstract][Full Text] [Related]
35. The mechanisms of inhibition of human IL 2 production. II. PGE2 induction of suppressor T lymphocytes.
Chouaib S; Chatenoud L; Klatzmann D; Fradelizi D
J Immunol; 1984 Apr; 132(4):1851-7. PubMed ID: 6230395
[TBL] [Abstract][Full Text] [Related]
36. Regulation of human immunoglobulin production in vitro by prostaglandin E2.
Staite ND; Panayi GS
Clin Exp Immunol; 1982 Jul; 49(1):115-22. PubMed ID: 6957277
[TBL] [Abstract][Full Text] [Related]
37. Head and neck squamous cell carcinoma cell line-induced suppression of in vitro lymphocyte proliferative responses.
Lapointe H; Lampe H; Banerjee D
Otolaryngol Head Neck Surg; 1992 Feb; 106(2):149-58. PubMed ID: 1738546
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin E2 regulation of human specific B-cell response: interaction with a monocyte product.
Emilie D; Crevon MC; Galanaud P
Clin Immunol Immunopathol; 1983 Dec; 29(3):415-23. PubMed ID: 6227436
[TBL] [Abstract][Full Text] [Related]
39. Anergy in sarcoidosis: the role of interleukin-1 and prostaglandins in the depressed in vitro lymphocyte response.
Hudspith BN; Brostoff J; McNicol MW; Johnson NM
Clin Exp Immunol; 1984 Aug; 57(2):324-30. PubMed ID: 6331921
[TBL] [Abstract][Full Text] [Related]
40. Reduced production of histamine-induced suppressor factor (HSF) by atopic mononuclear cells and decreased prostaglandin E2 output by HSF-stimulated atopic monocytes.
Matloff SM; Kiselis IK; Rocklin RE
J Allergy Clin Immunol; 1983 Oct; 72(4):359-64. PubMed ID: 6604743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
